Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 110

    1.

    Diarrhea and metformin in a diabetic clinic.

    Dandona P, Fonseca V, Mier A, Beckett AG.

    Diabetes Care. 1983 Sep-Oct;6(5):472-4.PMID: 6336343 [PubMed - indexed for MEDLINE]Related articles

    2.

    The prevalence of chronic diarrhea among diabetic patients.

    Lysy J, Israeli E, Goldin E.

    Am J Gastroenterol. 1999 Aug;94(8):2165-70.PMID: 10445544 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up.

    Fisman EZ, Tenenbaum A, Benderly M, Goldbourt U, Behar S, Motro M.

    Cardiology. 1999;91(3):195-202.PMID: 10516414 [PubMed - indexed for MEDLINE]Related articles

    4.

    Metformin as a cause of late-onset chronic diarrhea.

    Foss MT, Clement KD.

    Pharmacotherapy. 2001 Nov;21(11):1422-4.PMID: 11714216 [PubMed - indexed for MEDLINE]Related articles

    5.

    Role of metformin in treatment of diabetes mellitus.

    Vigneri R, Goldfine ID.

    Diabetes Care. 1987 Jan-Feb;10(1):118-22. Review.PMID: 3552509 [PubMed - indexed for MEDLINE]Related articles

    6.

    A retrospective chart review of uncontrolled use of metformin as an add-on therapy in type 2 diabetes.

    Johnson M, Krosnick A, Carson P, McDade AM, Laraway K.

    Clin Ther. 1998 Jul-Aug;20(4):691-8.PMID: 9737829 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Metformin in the treatment of type 2 diabetes in overweighted or obese patients]

    Martín Muñoz MC, Díaz JM, Muros Bayo JM, González Alvaro A, Costa Zamora P.

    An Med Interna. 2005 Dec;22(12):579-85. Spanish. PMID: 16454597 [PubMed - indexed for MEDLINE]Related articles

    10.

    An overview of metformin in the treatment of type 2 diabetes mellitus.

    Davidson MB, Peters AL.

    Am J Med. 1997 Jan;102(1):99-110. Review.PMID: 9209206 [PubMed - indexed for MEDLINE]Related articles

    11.

    Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage.

    Kosachunhanun N, Benjasuratwong Y, Mongkolsomlit S, Rawdaree P, Plengvidhya N, Leelawatana R, Bunnag P, Pratipanawatr T, Krittiyawong S, Suwanwalaikorn S, Deerochanawong C, Chetthakul T, Ngarmukos C, Komoltri C.

    J Med Assoc Thai. 2006 Aug;89 Suppl 1:S66-71.PMID: 17715836 [PubMed - indexed for MEDLINE]Related articles

    12.

    Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

    Bowker SL, Majumdar SR, Veugelers P, Johnson JA.

    Diabetes Care. 2006 Feb;29(2):254-8.PMID: 16443869 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.

    Evans JM, Ogston SA, Emslie-Smith A, Morris AD.

    Diabetologia. 2006 May;49(5):930-6. Epub 2006 Mar 9.PMID: 16525843 [PubMed - indexed for MEDLINE]Related articles

    16.

    Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.

    Bermúdez-Pirela VJ, Cano C, Medina MT, Souki A, Lemus MA, Leal EM, Seyfi HA, Cano R, Ciscek A, Bermúdez-Arias F, Contreras F, Israili ZH, Hernández-Hernández R, Valasco M.

    Am J Ther. 2007 Mar-Apr;14(2):194-202.PMID: 17414590 [PubMed - indexed for MEDLINE]Related articles

    18.

    Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

    Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

    Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles

    20.

    Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea.

    Lin KD, Chang YH, Wang CL, Yang YH, Hsiao PJ, Li TH, Shin SJ.

    Transl Res. 2008 Jun;151(6):309-14. Epub 2008 May 16.PMID: 18514142 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data